With Bluetooth technology there is remarkable improvement in adherence to inhaled and oral therapies for cystic fibrosis patients.
Cystic Fibrosis - Symptoms, Causes, Diagnosis, Treatment, Support Groups
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has still to find its cure
Cystic fibrosis is a genetic disease involving the mucus and sweat glands and the medical world has still to find its cure
‘With Bluetooth technology there is remarkable improvement in adherence to inhaled and oral therapies for cystic fibrosis patients.’
A new
pilot study from Ventura County Medical Center in Ventura, California,
shows remarkable improvement in adherence using Bluetooth technology.
For 28 days, patients used a Bluetooth-enabled medication delivery
and monitoring tool called eRapid™. The clinic used the technology to
gain rapid feedback on nebulizer use and used the data to reward
patients for adherence as a depression intervention method. Results not only showed 80% improvement in adherence but also 30% improvement in measures of airflow limitation and frequency of flare-ups of disease.
"eRapid™ decreases miscommunication and misunderstanding between the patient and the provider by replacing an error-prone self-reporting method with real-time data," says Dr. Chris Landon, lead researcher. "Ongoing assessment of the data by the health care team allows for active engagement between the patient and provider promoting shared decision making in individualized therapy and cognitive behavioral interventions."
Novel Low-Cost Sensor for Cystic Fibrosis Diagnosis Based on Citrate
A newly developed fluorescent sensor is highly sensitive and highly selective for chloride, the key diagnostic marker in cystic fibrosis.
A newly developed fluorescent sensor is highly sensitive and highly selective for chloride, the key diagnostic marker in cystic fibrosis.
Low Cost Sensor Developed To Diagnose Cystic Fibrosis
Cystic fibrosis is a common genetic disease within the white population in the United States. The disease occurs in 1 in 2,500 to 3,500 white newborns.
Cystic fibrosis is a common genetic disease within the white population in the United States. The disease occurs in 1 in 2,500 to 3,500 white newborns.
Gene Therapy May Help Treat Cystic Fibrosis Lung Disease
Two gene therapy vectors partially correct lung disease in a pig model of cystic fibrosis.
Two gene therapy vectors partially correct lung disease in a pig model of cystic fibrosis.
